FTLD-TDP assessment was available for 3584 (83%) of participants, ALS assessment was available for 4039 (94%), and 3324 participants (77%) had at least one regional TDP-43 assessment available. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.